Series A Funding
Wheeler Bio Announces Initial Closing of Series A Round Supporting New Biologics Drug Substance GMP Expansion In Oklahoma
Wheeler Bio
PR-M10-22-02Oct 05, 2022
Series A Funding
Biofidelity Raises $23M in Series A+ Financing Led by Octopus Ventures to Launch ASPYRE Technology
Biofidelity
PR-M02-22-04Feb 07, 2022
Series A
Stemson Therapeutics Secures $15M Series A Funding to Cure Hair Loss
Stemson Therapeutics
PR-M07-21-010Jul 21, 2021
Stem Cells
Curi Bio Raises $6M Series A Financing Round for iPSC-derived Predictive Platforms
Curi Bio
PR-M03-21-004-1062Mar 18, 2021
Financing
Syncona Founds Purespring with £45m in Series A Financing
Syncona Ltd
PR-M11-20-017Nov 19, 2020
Series A Financing
AI Startup Deep Longevity Launches With Series A Financing and New AI System to Tackle Aging-related Diseases
Deep Longevity
PR-M07-20-NI-022Jul 15, 2020
Financing
Immuneering Completes $17 Million Series A Financing
Immuneering Corporation
PR-M12-19-NI-023Dec 16, 2019
Funding
Alizé Pharma 3 Raises €67 Million ($75 million) in Series A from an International Syndicate
Amolyt Pharma
PR-M08-19-NI-014Aug 06, 2019
Immuno-oncology Startup
Polsky Center for Entrepreneurship and Innovation Supports University of Chicago Professor in Founding Immuno-oncology Startup
The Polsky Center for Entrepreneurship and Innovation
PR-M07-19-NI-047Jul 17, 2019
Series A Financing
Tangen Biosciences Announces $9 Million Series A Financing to Accelerate Development of Disruptive Molecular Diagnostic Platform
Tangen Biosciences
PR-M06-19-NI-041Jun 24, 2019
Series A Financing
Syncona founds Quell Therapeutics with £35 million Series A Financing
Syncona Ltd
PR-M05-19-NI-063May 22, 2019
Funding
BillionToOne Announces $15 Million Series A, Co-Led by Hummingbird and NeoTribe
BillionToOne
PR-M04-19-NI-005-2795Apr 02, 2019
Investment
Embleema Closes $3.7M Series A Funding Round and Joins Techstars Alchemist Blockchain Accelerator Program
Embleema
PR-M02-19-NI-013Feb 07, 2019
Financing
Entrada Therapeutics Raises $59 Million Series A to Advance Intracellular Biologics Platform
Entrada Therapeutics
PR-M12-18-NI-081Dec 27, 2018